An Efficacy and Safety Study to Compare Three Doses of BEA 2180 BR to Tiotropium and Placebo in the Respimat Inhaler.
Clinical trial NCT00528996 · COMPLETED
Trial details
- NCT number
- NCT00528996
- Sponsor
- Boehringer Ingelheim
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2007-09-06
- Primary completion
- 2009-05-05
- Enrollment
- 2080
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.